Medpace (MEDP) is in a potential buy range with its next earnings report scheduled for Apr. 26. The medical stock is about 3% above a 177.22 buy point from a second-stage consolidation. Be aware that buying close to when a stock reports can be risky. You don’t know how the stock will report and how the market will react, and…
